Pluri (PLUR) Non-Current Deffered Revenue (2011 - 2015)

Pluri (PLUR) reported Non-Current Deffered Revenue of $2.4 million for Q3 2015, down 13.77% year-over-year from $2.8 million in Q3 2014, and down 3.85% quarter-over-quarter from $2.5 million in Q2 2015.

Pluri (PLUR) Non-Current Deffered Revenue (2011 - 2015) Analysis & Trends

Pluri (PLUR) has 5 years of Non-Current Deffered Revenue data on file, last reported at $2.4 million in Q3 2015.

  • Non-Current Deffered Revenue for Q3 2015 came in at $2.4 million, down 13.77% year-over-year; the trailing twelve-month figure through Sep 2015 was $2.4 million (down 13.77% YoY), and the FY2015 annual result was $2.5 million, down 13.31% from the prior year.
  • Non-Current Deffered Revenue retreated to $2.4 million in Q3 2015 per PLUR's latest filing, from $2.5 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $3.9 million in Q3 2011 and troughed at $3116.0 in Q4 2012.
  • A 5-year average of $2.9 million and a median of $3.0 million in 2013 frame the typical range for Non-Current Deffered Revenue.
  • The sharpest annual moves came in 2012 and 2013: Non-Current Deffered Revenue plunged 99.92% in 2012, then jumped 97332.61% in 2013.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $3.7 million in 2011, then sank by 99.92% to $3116.0 in 2012, then jumped by 97332.61% to $3.0 million in 2013, then declined by 12.48% to $2.7 million in 2014, then decreased by 10.69% to $2.4 million in 2015.
  • Business Quant data shows PLUR's Non-Current Deffered Revenue at $2.4 million in Q3 2015, $2.5 million in Q2 2015, and $2.7 million in Q4 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn -
9 Abivax 95.45 Bn 95.45 Bn - -
10 Pluri 21.85 Mn 22.34 Mn 86,000.00 -

Historic Data

Download Data
DateValue
Sep 30, 2015 2.37 Mn
Jun 30, 2015 2.47 Mn
Dec 31, 2014 2.66 Mn
Sep 30, 2014 2.75 Mn
Jun 30, 2014 2.85 Mn
Mar 31, 2014 2.94 Mn
Dec 31, 2013 3.04 Mn
Sep 30, 2013 3.13 Mn
Jun 30, 2013 3.23 Mn
Mar 31, 2013 2.92 Mn
Dec 31, 2012 3,116.00
Sep 30, 2012 3.31 Mn
Jun 30, 2012 3.51 Mn
Mar 31, 2012 3.46 Mn
Dec 31, 2011 3.69 Mn
Sep 30, 2011 3.92 Mn